Literature DB >> 34735597

[Still's syndrome-similarities and differences between the juvenile and adult forms].

Andrea Regel1, Dirk Föll2, Martin A Kriegel3,4,5.   

Abstract

Still's syndrome includes systemic juvenile idiopathic arthritis (sJIA) and the adult form of Still's disease (adult-onset Still's disease, AOSD). Except for age, there are many similarities between sJIA and AOSD. A biphasic disease model is currently put forth. At disease onset, autoinflammation predominates, which is caused by dysregulation of the innate immune system. Later on, the disease can progress to a chronic-articular form, which is predominantly mediated by the adaptive immune system and is consequently due to autoimmunity. The "window-of-opportunity" hypothesis is based on this biphasic model and supports the assumption that an early, targeted therapy with cytokine blockade can prevent disease progression to chronic destructive arthritis. Macrophage activation syndrome (MAS) is a serious complication of the so-called cytokine storm during the systemic phase of the disease. Clinically, there are many similarities between sJIA and AOSD. Recurrent fever, a fleeting, salmon-colored rash, and arthralgia/arthritis are common signs and symptoms of both sJIA and AOSD. The few differences are mainly related to the therapies and their side effects in children versus adults. In addition, the contribution of genetics to pathogenesis is more pronounced in sJIA compared to AOSD, but there are also smooth transitions in this respect and both diseases are heavily influenced by exogenous factors such as microbial triggers. Future research aspects could include additional investigation of these triggers such as viruses, bacteria, or dysbiosis of the human microbiome.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Autoinflammation; Cytokines; Immune system; Juvenile arthritis; Macrophage activation syndrome

Mesh:

Substances:

Year:  2021        PMID: 34735597      PMCID: PMC8816857          DOI: 10.1007/s00393-021-01117-w

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  40 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

2.  Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

Authors:  Peter A Nigrovic; Melissa Mannion; Femke H M Prince; Andrew Zeft; C Egla Rabinovich; Marion A J van Rossum; Elisabetta Cortis; Manuela Pardeo; Paivi M Miettunen; Ginger Janow; James Birmingham; Aaron Eggebeen; Erin Janssen; Andrew I Shulman; Mary Beth Son; Sandy Hong; Karla Jones; Norman T Ilowite; Randy Q Cron; Gloria C Higgins
Journal:  Arthritis Rheum       Date:  2011-02

3.  Still's disease in the adult.

Authors:  E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

Review 4.  Host-microbiota interactions in immune-mediated diseases.

Authors:  William E Ruff; Teri M Greiling; Martin A Kriegel
Journal:  Nat Rev Microbiol       Date:  2020-05-26       Impact factor: 60.633

5.  Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.

Authors:  Kenneth M Kaufman; Bolan Linghu; Joseph D Szustakowski; Ammar Husami; Fan Yang; Kejian Zhang; Alexandra H Filipovich; Ndate Fall; John B Harley; N R Nirmala; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

6.  Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Authors:  Fabrizio De Benedetti; Hermine I Brunner; Nicolino Ruperto; Andrew Kenwright; Stephen Wright; Inmaculada Calvo; Ruben Cuttica; Angelo Ravelli; Rayfel Schneider; Patricia Woo; Carine Wouters; Ricardo Xavier; Lawrence Zemel; Eileen Baildam; Ruben Burgos-Vargas; Pavla Dolezalova; Stella M Garay; Rosa Merino; Rik Joos; Alexei Grom; Nico Wulffraat; Zbigniew Zuber; Francesco Zulian; Daniel Lovell; Alberto Martini
Journal:  N Engl J Med       Date:  2012-12-20       Impact factor: 91.245

Review 7.  Adult-Onset Still's Disease: Clinical Aspects and Therapeutic Approach.

Authors:  Stylianos Tomaras; Carl Christoph Goetzke; Tilmann Kallinich; Eugen Feist
Journal:  J Clin Med       Date:  2021-02-12       Impact factor: 4.241

8.  Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.

Authors:  Claas H Hinze; Dirk Holzinger; Elke Lainka; Johannes-Peter Haas; Fabian Speth; Tilmann Kallinich; Nikolaus Rieber; Markus Hufnagel; Annette F Jansson; Christian Hedrich; Hanna Winowski; Thomas Berger; Ivan Foeldvari; Gerd Ganser; Anton Hospach; Hans-Iko Huppertz; Kirsten Mönkemöller; Ulrich Neudorf; Elisabeth Weißbarth-Riedel; Helmut Wittkowski; Gerd Horneff; Dirk Foell
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-22       Impact factor: 3.054

9.  Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.

Authors:  Nienke M Ter Haar; E H Pieter van Dijkhuizen; Joost F Swart; Annet van Royen-Kerkhof; Ayman El Idrissi; Arjen P Leek; Wilco de Jager; Mark C H de Groot; Saskia Haitjema; Dirk Holzinger; Dirk Foell; Jorg van Loosdregt; Nico M Wulffraat; Sytze de Roock; Sebastiaan J Vastert
Journal:  Arthritis Rheumatol       Date:  2019-05-25       Impact factor: 10.995

10.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  1 in total

Review 1.  Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Authors:  Jasper F Nies; Udo Schneider; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.